These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8666940)

  • 1. Inhibition of interleukin-1 responsiveness by type II receptor gene transfer: a surface "receptor" with anti-interleukin-1 function.
    Re F; Sironi M; Muzio M; Matteucci C; Introna M; Orlando S; Penton-Rol G; Dower SK; Sims JE; Colotta F; Mantovani A
    J Exp Med; 1996 Apr; 183(4):1841-50. PubMed ID: 8666940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene transfer-mediated expression of physiological numbers of the type II decoy receptor in a myelomonocytic cellular context dampens the response to interleukin-1.
    Penton Rol G; Polentarutti N; Sironi M; Saccani S; Introna M; Mantovani A
    Eur Cytokine Netw; 1997 Sep; 8(3):265-9. PubMed ID: 9346359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells.
    Colotta F; Orlando S; Fadlon EJ; Sozzani S; Matteucci C; Mantovani A
    J Exp Med; 1995 Jun; 181(6):2181-6. PubMed ID: 7760005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulated expression and release of the IL-1 decoy receptor in human mononuclear phagocytes.
    Colotta F; Saccani S; Giri JG; Dower SK; Sims JE; Introna M; Mantovani A
    J Immunol; 1996 Apr; 156(7):2534-41. PubMed ID: 8786316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of metalloproteases in the release of the IL-1 type II decoy receptor.
    Orlando S; Sironi M; Bianchi G; Drummond AH; Boraschi D; Yabes D; Mantovani A
    J Biol Chem; 1997 Dec; 272(50):31764-9. PubMed ID: 9395521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The type II decoy receptor of IL-1 inhibits murine collagen-induced arthritis.
    Bessis N; Guéry L; Mantovani A; Vecchi A; Sims JE; Fradelizi D; Boissier MC
    Eur J Immunol; 2000 Mar; 30(3):867-75. PubMed ID: 10741403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfected type II interleukin-1 receptor impairs responsiveness of human keratinocytes to interleukin-1.
    Bossù P; Visconti U; Ruggiero P; Macchia G; Muda M; Bertini R; Bizzarri C; Colagrande A; Sabbatini V; Maurizi G
    Am J Pathol; 1995 Dec; 147(6):1852-61. PubMed ID: 7495308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene transfer of type 1 interleukin-1 receptor extracellular-domain complementary DNA into rabbit synovial cell line HIG-82 results in cellular blockade of interleukin-1 signal transduction.
    Mehraban F; Kasturi S
    Arthritis Rheum; 1998 Mar; 41(3):515-24. PubMed ID: 9506580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF-alpha, unlike other pro- and anti-inflammatory cytokines, induces rapid release of the IL-1 type II decoy receptor in human myelomonocytic cells.
    Orlando S; Matteucci C; Fadlon EJ; Buurman WA; Bardella MT; Colotta F; Introna M; Mantovani A
    J Immunol; 1997 Apr; 158(8):3861-8. PubMed ID: 9103454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low affinity binding of interleukin-1 beta and intracellular signaling via NF-kappa B identify Fit-1 as a distant member of the interleukin-1 receptor family.
    Reikerstorfer A; Holz H; Stunnenberg HG; Busslinger M
    J Biol Chem; 1995 Jul; 270(30):17645-8. PubMed ID: 7629057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness.
    Lang D; Knop J; Wesche H; Raffetseder U; Kurrle R; Boraschi D; Martin MU
    J Immunol; 1998 Dec; 161(12):6871-7. PubMed ID: 9862719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of intracellular interleukin-1 beta signals via type II interleukin-1 receptor in human gingival fibroblasts.
    Chou HH; Takashiba S; Maeda H; Naruishi K; Nishimura F; Arai H; Lu H; Murayama Y
    J Dent Res; 2000 Sep; 79(9):1683-8. PubMed ID: 11023264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selectivity release of the type II decoy IL-1 receptor.
    Orlando S; Polentarutti N; Mantovani A
    Cytokine; 2000 Jul; 12(7):1001-6. PubMed ID: 10880245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of the interleukin-1-receptor-associated kinase (IRAK-1) in interleukin-1 beta-stimulated nuclear factor kappa B (NF-kappa B) pathway activation: IRAK-1 associates with the NF-kappa B essential modulator (NEMO) upon receptor stimulation.
    Cooke EL; Uings IJ; Xia CL; Woo P; Ray KP
    Biochem J; 2001 Oct; 359(Pt 2):403-10. PubMed ID: 11583588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-expression of mRNA for type I and type II interleukin-1 receptors and the IL-1 receptor accessory protein correlates to IL-1 responsiveness.
    Wesche H; Neumann D; Resch K; Martin MU
    FEBS Lett; 1996 Aug; 391(1-2):104-8. PubMed ID: 8706893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type II interleukin-1 receptor is not expressed in cultured endothelial cells and is not involved in endothelial cell activation.
    Colotta F; Sironi M; Borrè A; Pollicino T; Bernasconi S; Boraschi D; Mantovani A
    Blood; 1993 Mar; 81(5):1347-51. PubMed ID: 8443394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.
    Smeets RL; Joosten LA; Arntz OJ; Bennink MB; Takahashi N; Carlsen H; Martin MU; van den Berg WB; van de Loo FA
    Arthritis Rheum; 2005 Jul; 52(7):2202-11. PubMed ID: 15986350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of critical residues in the cytoplasmic domain of the human interleukin-5 receptor alpha chain required for growth signal transduction.
    Cornelis S; Fache I; Van der Heyden J; Guisez Y; Tavernier J; Devos R; Fiers W; Plaetinck G
    Eur J Immunol; 1995 Jul; 25(7):1857-64. PubMed ID: 7542592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The type II "receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor.
    Re F; Muzio M; De Rossi M; Polentarutti N; Giri JG; Mantovani A; Colotta F
    J Exp Med; 1994 Feb; 179(2):739-43. PubMed ID: 8294881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A chimeric type II/type I interleukin-1 receptor can mediate interleukin-1 induction of gene expression in T cells.
    Heguy A; Baldari CT; Censini S; Ghiara P; Telford JL
    J Biol Chem; 1993 May; 268(14):10490-4. PubMed ID: 8387521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.